
Please try another search
Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.
Name | Age | Since | Title |
---|---|---|---|
Rashid Ahmed Maula Bux | - | 2014 | Founder, CEO, President & Director |
Bill Good | - | - | Member of Media Advisory Board |
Alfred Rives Berkeley | 77 | 2021 | Member of Advisory Board |
Bramhanand Ramjiawan | - | 2014 | Independent Director |
Brian Kai-Ming Cheng | - | 2014 | Chief Technical Officer & Independent Director |
Theresa Peterson | - | 2024 | Member of Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review